Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan subsidiary starts operations in India
Yahoo/AP
Monday, August 6, 2012 - 10:56am
tags:
India, Mylan, HIV, AIDS
Rethinking Idenix Pharma in Wake of Bristol's Hep C Blow Up
TheStreet.com
Monday, August 6, 2012 - 10:46am
tags:
hepatitis C, Idenix, Bristol-Myers Squibb, BMS-094
StemCells' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Monday, August 6, 2012 - 10:32am
tags:
earnings, StemCells
Saladax Biomedical enters master collaboration agreement with Bristol-Myers
Yahoo/Fly on the Wall
Monday, August 6, 2012 - 10:30am
tags:
Saladax, Bristol-Myers Squibb
Earnings Beat at Valeant, Guides Up
Yahoo/Zacks
Monday, August 6, 2012 - 10:29am
tags:
Valeant Pharmaceuticals, earnings
Idenix enters into development, commercialization pact with Novartis
Healthcare Global
Sunday, August 5, 2012 - 11:17am
tags:
Idenix, Novartis, hepatitis C, Tyzeka, hepatitis B
SEC opens Teva bribery probe
Globes, Israel
Sunday, August 5, 2012 - 11:15am
tags:
Teva Pharmaceuticals, SEC, legal
China Detains 2,000 Suspects in Counterfeit Drug Scheme
WSJ
Sunday, August 5, 2012 - 11:14am
tags:
China
Cash Rich, Fast Growing Biotech With Further Upside Ahead
Seeking Alpha
Sunday, August 5, 2012 - 11:12am
tags:
Spectrum Pharmaceuticals
Will Jazz Pharmaceuticals Beat These Analyst Estimates?
Motley Fool
Sunday, August 5, 2012 - 11:11am
tags:
Jazz Pharmaceuticals, earnings
Arena Pharma Second Quarter Earnings Sneak Peek
Wall Street Cheat Street
Sunday, August 5, 2012 - 11:11am
tags:
Arena Pharmaceuticals, earnings
What to Expect from Cornerstone Therapeutics
Motley Fool
Sunday, August 5, 2012 - 11:10am
tags:
Cornerstone Therapeutics
Earnings Preview: Orexigen Therapeutics
Seeking Alpha
Saturday, August 4, 2012 - 12:56pm
tags:
Orexigen, earnings
K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations
Sacramento Bee, CA
Saturday, August 4, 2012 - 12:55pm
tags:
KV Pharmaceutical
Aventis to Pay $828,500 in Drug Pricing Settlement
Equities.com
Saturday, August 4, 2012 - 12:54pm
tags:
Aventis, legal
Sun Pharma looks to acquire German genetic drug maker
Healthcare Global
Saturday, August 4, 2012 - 12:52pm
tags:
Sun Pharma, M&A
SEC Subpoenas Teva Pharmaceutical in Bribery Probe
WSJ
Saturday, August 4, 2012 - 12:49pm
tags:
Teva Pharmaceuticals, SEC, legal
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Digital Journal
Saturday, August 4, 2012 - 12:49pm
tags:
Takeda, Actos, diabetes, type 2 diabetes
Forget The Patent Cliff, This Is The Best Way To Invest In Big Pharma Now
istockanalyst
Saturday, August 4, 2012 - 12:47pm
tags:
OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
PharmaLive
Saturday, August 4, 2012 - 12:45pm
tags:
OGX-427, custirsen, non-small cell lung cancer, OncoGenex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.